Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600

被引:142
作者
Huh, KW
DeMasi, J
Ogawa, H
Nakatani, Y
Howley, PM
Münger, K
机构
[1] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
apoptosis; cervical carcinogensis; retinoblastoma tumor suppressor;
D O I
10.1073/pnas.0505337102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The human papillomavirus type 16 (HPV-16) E7 gene encodes a multifunctional oncoprotein that can subvert multiple cellular regulatory pathways. The best-known cellular targets of the HPV-16 E7 oncoprotein are the retinoblastoma tumor suppressor protein pRB and the related pocket proteins p107 and p130. However, there is ample evidence that E7 has additional cellular targets that contribute to its transforming potential. We isolated HPV-16 E7 associated cellular protein complexes by tandem affinity purification and mass spectrometry and identified the 600-kDa retinoblastoma protein associated factor, p600, as a cellular target of E7. Association of E7 with p600 is independent of the pocket proteins and is mediated through the N terminal E7 domain, which is related to conserved region 1 of the adenovirus E1A protein and importantly contributes to cellular transformation independent of pRB binding. Depletion of p600 protein levels by RNA interference substantially decreased anchorage-independent growth in HPV-positive and -negative human cancer cells. Therefore, p600 is a cellular target of E7 that regulates cellular pathways that contribute to anchorage-independent growth and cellular transformation.
引用
收藏
页码:11492 / 11497
页数:6
相关论文
共 42 条
[21]  
MADURA K, 1993, J BIOL CHEM, V268, P12046
[22]   CDD: a curated Entrez database of conserved domain alignments [J].
Marchler-Bauer, A ;
Anderson, JB ;
DeWeese-Scott, C ;
Fedorova, ND ;
Geer, LY ;
He, SQ ;
Hurwitz, DI ;
Jackson, JD ;
Jacobs, AR ;
Lanczycki, CJ ;
Liebert, CA ;
Liu, CL ;
Madej, T ;
Marchler, GH ;
Mazumder, R ;
Nikolskaya, AN ;
Panchenko, AR ;
Rao, BS ;
Shoemaker, BA ;
Simonyan, V ;
Song, JS ;
Thiessen, PA ;
Vasudevan, S ;
Wang, YL ;
Yamashita, RA ;
Yin, JJ ;
Bryant, SH .
NUCLEIC ACIDS RESEARCH, 2003, 31 (01) :383-387
[23]   Biological activities and molecular targets of the human papillomavirus E7 oncoprotein [J].
Münger, K ;
Basile, JR ;
Duensing, S ;
Eichten, A ;
Gonzalez, SL ;
Grace, M ;
Zacny, VL .
ONCOGENE, 2001, 20 (54) :7888-7898
[24]   Mechanisms of human papillomavirus-induced oncogenesis [J].
Münger, K ;
Baldwin, A ;
Edwards, KM ;
Hayakawa, H ;
Nguyen, CL ;
Owens, M ;
Grace, M ;
Huh, K .
JOURNAL OF VIROLOGY, 2004, 78 (21) :11451-11460
[25]   COMPLEX-FORMATION OF HUMAN PAPILLOMAVIRUS-E7 PROTEINS WITH THE RETINOBLASTOMA TUMOR SUPPRESSOR GENE-PRODUCT [J].
MUNGER, K ;
WERNESS, BA ;
DYSON, N ;
PHELPS, WC ;
HARLOW, E ;
HOWLEY, PM .
EMBO JOURNAL, 1989, 8 (13) :4099-4105
[26]  
Nakatani Y, 2003, METHOD ENZYMOL, V370, P430
[27]   THE HUMAN PAPILLOMAVIRUS TYPE-16 E7 GENE ENCODES TRANSACTIVATION AND TRANSFORMATION FUNCTIONS SIMILAR TO THOSE OF ADENOVIRUS-E1A [J].
PHELPS, WC ;
YEE, CL ;
MUNGER, K ;
HOWLEY, PM .
CELL, 1988, 53 (04) :539-547
[28]   STRUCTURE-FUNCTION ANALYSIS OF THE HUMAN PAPILLOMAVIRUS TYPE-16 E7 ONCOPROTEIN [J].
PHELPS, WC ;
MUNGER, K ;
YEE, CL ;
BARNES, JA ;
HOWLEY, PM .
JOURNAL OF VIROLOGY, 1992, 66 (04) :2418-2427
[29]   Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells [J].
Psyrri, A ;
DeFilippis, RA ;
Edwards, APB ;
Yates, KE ;
Manuelidis, L ;
DiMaio, D .
CANCER RESEARCH, 2004, 64 (09) :3079-3086
[30]   Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue [J].
Reinstein, E ;
Scheffner, M ;
Oren, M ;
Ciechanover, A ;
Schwartz, A .
ONCOGENE, 2000, 19 (51) :5944-5950